Recent findings on the impact of ErbB receptors status on prognosis and therapy of head and neck squamous cell carcinoma

Recent findings on the impact of ErbB receptors status on prognosis and therapy of head and neck squamous cell carcinoma

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer type, has often an aggressive course and is poorly responsive to current therapeutic approaches, so that 5-year survival rates for patients diagnosed with advanced disease is lower than 50%. The Epidermal Growth Factor Rec...

Full description

Bibliographic Details
Main Authors: Camilla Palumbo, Monica Benvenuto, Chiara Focaccetti, Loredana Albonici, Loredana Cifaldi, Alessandra Rufini, Daniela Nardozi, Valentina Angiolini, Arianna Bei, Laura Masuelli, Roberto Bei
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Medicine
Subjects:
head and neck squamous cell carcinoma
EGFR
ErbB receptors
Cetuximab
immune checkpoint inhibitors
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1066021/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2023.1066021/full

Similar Items